Rocket Lab is trading at €67.20 (+6.50%) after its 20-launch Synspective agreement, its largest commercial Electron contract, pushed its backlog above 100 missions.
- Coverage links the deal to buying interest; Citi’s new Buy rating and $105 target are also cited as support.
- Broader risk-on sentiment may add support, with major U.S. indices up; the company-specific deal is the clearest reported catalyst.